🔎 Trials Near Me

Home › Obesity › NCT05861973

SMARTer Weight Loss Management

Recruiting

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Over 18 years old
* BMI of ≥25, weight \<396 lbs
* Must own a Smartphone, and be willing to install the SMARTer app
* Not enrolled in a formal weight loss program

Exclusion Criteria:

* Cerebrovascular accident or myocardial infarction within six months of enrollment
* Diabetes treated with insulin
* Pregnancy, lactation or intended pregnancy
* Active suicidal ideation
* Anorexia or bulimia
* Requiring an assistive device for mobility
* Taking weight loss medications, such as GLP-1 agonists

About the study

The SMARTer trial will be a three-arm, randomized controlled non-inferiority trial that compares the optimized, adaptive SMARTer intervention, fixed DPP, and Self-Guided (Control). The trial will address whether a scalable, stepped-care intervention can stand up to gold-standard DPP by achieving comparable weight loss at a lower cost. Alongside evaluation of clinical non-inferiority, a comprehensive economic evaluation will inform relative affordability. Cost information is important to inform treatment policy and change standard of care, but is sorely lacking for behavioral interventions. The SMARTer intervention reduces costs by initially offering minimal intervention to all and stepping up to offer more costly treatment components only to non-responders who fail to attain the target weight loss. A rigorous economic evaluation planned and designed alongside the SMARTer trial will provide an accurate, robust head-to-head comparison of costs, cost-effectiveness, and projected lifetime health care costs between the three arms.

What is being tested

Sponsor: Florida State University · Participants: 492 · Started: Jun 25, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT05861973

Locations in the U.S.

FloridaFlorida State University, Tallahassee

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.